Hausman, US
Adam Hausman, Jacksonville, FL US
Patent application number | Description | Published |
---|---|---|
20150297272 | CONTOURABLE PLATE - A medical device that may include a main body and a plurality of hooks. The main body includes a length extending along an axis between first and second ends. The main body may be deformable such that the axis forms an arch shape corresponding to a shape of a mandibular jaw or a maxillary jaw. The main body may include a plurality of sections each having first and second edges defining a first width and a plurality of openings disposed between the first and second edges and extending through a thickness of the main body. The main body may include a plurality of recessed portions defining a second width disposed between adjacent ones of the sections. Each of the hooks may extend from a corresponding one of the sections. | 10-22-2015 |
Andrew Hausman, Summit, NJ US
Patent application number | Description | Published |
---|---|---|
20090292638 | Complementary Trading Of Interests - Methods, systems, and computer program products for automatically proposing currency exchange, hedging, and other trades in financial interests. A trader proposing or accepting a trade in a financial interest is presented with terms of or a prompt regarding a proposed complementary trade in a related interest. | 11-26-2009 |
David Hausman, Lancaster, PA US
Patent application number | Description | Published |
---|---|---|
20150237881 | HEAT RESISTANT CHOCOLATE - The present invention provides a heat resistant fat based confection. The heat resistance of the confection may be conferred either via inclusion of a polyol and at least one other thermal structuring component in the fat based confection, or via preparation of a premix comprising the polyol and at least one other component of the confection, or a combination of these. Methods of making the fat based confection, and packaged fat based confections, are also provided. | 08-27-2015 |
David Hausman, Elizabethtown, PA US
Patent application number | Description | Published |
---|---|---|
20150251844 | HEAT RESISTANT CHOCOLATE - The present invention provides a heat resistant fat based confection. The heat resistance of the confection may be conferred either via inclusion of a polyol and at least one other thermal structuring component in the fat based confection, or via preparation of a premix comprising the polyol and at least one other component of the confection, or a combination of these. Methods of making the fat based confection, and packaged fat based confections, are also provided. | 09-10-2015 |
20150257407 | HEAT RESISTANT CHOCOLATE - The present invention provides a heat resistant fat based confection. The heat resistance of the confection may be conferred either via inclusion of a polyol and at least one other thermal structuring component in the fat based confection, or via preparation of a premix comprising the polyol and at least one other component of the confection, or a combination of these. Methods of making the fat based confection, and packaged fat based confections, are also provided. | 09-17-2015 |
David J. Hausman, Lancaster, PA US
Patent application number | Description | Published |
---|---|---|
20080317891 | Edible Products Having A High Cocoa Polyphenol Content and Improved Flavor and The Milled Cocoa Extracts Used Therein - Milling dry extracts containing cocoa polyphenols (CPs) to reduce the particle size improves the flavor of edible products (e.g., foods, medical foods, nutritional supplements, and pharmaceuticals) or additives containing the milled cocoa extracts. The products, e.g., chocolates, are less astringent and less bitter. The mean particle size after milling is less than about 15 microns, preferably less than about 10 microns, and most preferably less than about 5 microns. The total CP content of the milled extracts is at least about 300 milligrams and preferably about 300 to about 700 milligrams per gram of milled extract. The additives consist essentially of (i) the milled high CP cocoa extract and (ii) a fat (e.g., cocoa butter), an oil (e.g., vegetable oil), or a syrup (e.g., corn syrup). | 12-25-2008 |
20150352163 | EDIBLE PRODUCTS HAVING A HIGH COCOA POLYPHENOL CONTENT AND IMPROVED FLAVOR AND THE MILLED COCOA EXTRACTS USED THEREIN - Milling dry extracts containing cocoa polyphenols (CPs) to reduce the particle size improves the flavor of edible products (e.g., foods, medical foods, nutritional supplements, and pharmaceuticals) or additives containing the milled cocoa extracts. The products, e.g., chocolates, are less astringent and less bitter. The mean particle size after milling is less than about 15 microns, preferably less than about 10 microns, and most preferably less than about 5 microns. The total CP content of the milled extracts is at least about 300 milligrams and preferably about 300 to about 700 milligrams per gram of milled extract. The additives consist essentially of (i) the milled high CP cocoa extract and (ii) a fat (e.g., cocoa butter), an oil (e.g., vegetable oil), or a syrup (e.g., corn syrup). | 12-10-2015 |
Diana F. Hausman, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20110165121 | USE OF PEGYLATED TYPE III INTERFERONS FOR THE TREATMENT OF HEPATITIS C - Methods for treating human patients infected with the hepatitis C virus using pegylated Type III Interferons (IL-28A, IL-28B and IL-29) alone or in combination with other antiviral agents. | 07-07-2011 |
20120219617 | MUC1 Based Glycolipopeptide Vaccine with Adjuvant - Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer. | 08-30-2012 |
20120282329 | MUC1 Based Glycolipopeptide Vaccine with Adjuvant - Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer. | 11-08-2012 |
20130129720 | Combination Cancer Therapies with Wortmannin Analogs - Provided herein are combination therapies for the treatment of certain cancers in a subject by administering a combination of a therapeutic and a wortmannin analog to that subject. | 05-23-2013 |
20130131156 | Cancer Treatment with Wortmannin Analogs - Provided herein are certain therapeutically effective dosing regimens for treatment of cancers with wortmannin analogs. | 05-23-2013 |
20150064240 | MUC1 Based Glycolipopeptide Vaccine with Adjuvant - Provided herein are liposomal glycolipopeptidic vaccine formulations comprising an adjuvant and an immunogen for immunotherapy and/or treatment of cancer. | 03-05-2015 |
Dorothy Hausman, Watkinsville, GA US
Patent application number | Description | Published |
---|---|---|
20100190686 | NOVEL SECRETED PROTEINS OF ADIPOCYTES FOR DIAGNOSTIC PURPOSES - The present invention relates to the discovery of polypeptide biomarkers excreted into the blood stream (serum or plasma) and/or urine from adipocytes and their use to determine the existence of metabolic syndrome (prediabetic) and/or diabetic conditions (including type 2 diabetes) including insulin resistance and/or glucose intolerance, their use to monitor the state of metabolic syndrome or diabetes toward a state of control and/or cure of the disease state or condition and their use to monitor the long-term health of the patient by determining the existence of metabolic syndrome (prediabetic conditions insulin resistance and/or glucose intolerance) or the existence of type 2 diabetes and to identify potential antidiabetes agents. Methods of identifying potential agents to be used in the treatment of metabolic syndrome and/or type2 diabetes and assays for assisting in the diagnosis of metabolic syndrome and/or type 2 diabetes are additional aspects of the invention. Lipoprotein lipase; Quiescin Q6; Cathepsin B; Complement Component 6; Hippocampal Cholinergic Neurostimulating Protein (HCNP); Serine Protease Inhibitor 2C; Adiponectin; Angiotensinogen (angiotensin); Cyclophilin A; Laminin B1 subunit 1; cartilage glycoprotein 39; complement factor MASP-3 (MASP-3); Niemann-Pick disease, type C2, isoform CRA b (NPC2); Tetranectin; tissue inhibitor of metalloproteinase 2 (TIMP2); Superoxide dismutase secreted; and Spondin 1 | 07-29-2010 |
Harley Hausman, Earp, CA US
Patent application number | Description | Published |
---|---|---|
20160051449 | BABY BOTTLE HOLDING DEVICES, SYSTEMS AND METHODS - A support system for a baby bottle has a support body having a generally cylindrical portion. A channel is defined within the support body. A slot is defined between slot edges of the support body extending between a first end portion and a second end portion. First and second handle portions are coupled to the support body. The first and second handle portions are coupled to the support body at an angle less than about 120 degrees apart from each other about a surface of the support body. The support body is sized and configured to support a baby bottle positioned within the channel defined within the support body. In some embodiments, the first and second handle portions have handle grip portions that are coupled to the support body at an angle between about 5 degrees and about 30 degrees relative to a surface of the support body. | 02-25-2016 |
Howard Hausman, Hauppauge, NY US
Patent application number | Description | Published |
---|---|---|
20110064127 | MEASURING SATELLITE LINEARITY FROM EARTH USING A LOW DUTY CYCLE PULSED MICROWAVE SIGNAL - System for measuring satellite downlink amplifier linearity includes a pulsed signal generator for selectively generating low duty cycle pulses. A linear transmitter uplink amplifier is provided for amplifying the low duty cycle pulses and generating an uplink signal. An antenna transmits the amplified uplink signal to an orbiting satellite. A downlink amplifier in the satellite generates a downlink signal for re-transmission to an Earth-based antenna. A pulse receiver is provided for receiving the downlink signal and providing information regarding the transfer function of the downlink amplifier. Preferably, a delayed trigger circuit is coupled to the pulse signal generator for activating the pulsed signal generator after a time delay substantially corresponding to the propagation times of the uplink and downlink signals. By altering the duty cycles of the uplink signals while maintaining the peak power level the average powers transmitted to the downlink amplifiers can be changed to modify the power levels of the downlink signals to provide more complete information regarding the transfer functions of the downlink amplifiers. | 03-17-2011 |
20110065381 | METHOD OF TRANSMITTING HIGHER POWER FROM A SATELLITE BY MORE EFFICIENTLY USING THE EXISTING SATELLITE POWER AMPLIFIERS - A method of enhancing the power transmitted from a satellite includes the steps of modulating a carrier signal at an Earth station. The non-linearity is established of a downlink amplifier on the satellite. The modulated carrier signal is to compensate for the non-linearity of the downlink and/or the uplink amplifiers. The predistorted modulated carrier signal is transmitted in an uplink to the satellite. The uplink carrier is amplified in the downlink amplifier. A downlink signal is to an Earth station, whereby the downlink signal compensates for non-linearities in the downlink amplifier to thereby optimize amplification with minimum distortion of the signals. A system for implementing the method is described. | 03-17-2011 |
John M. Hausman, San Luis Obispo, CA US
Patent application number | Description | Published |
---|---|---|
20090037462 | SINGLE-OPERATION ON-LINE SCHEMA EVOLUTION - A method for modifying an original data object in a database using a single command is disclosed. The single command is first validated. Once the command has been validated a ghost data object is created using the new definition. The ghost data object is populated with data from the original object. The transaction log records from the original data object are applied to the ghost data object. The original data object is then locked for exclusive access. The final transaction log records from the original data object are applied to the ghost data object. In the final step the database switches to the new data object. Dependent objects are automatically transformed as part of the same operation. | 02-05-2009 |
Kristen A. Hausman, Austin, TX US
Patent application number | Description | Published |
---|---|---|
20130326193 | PROCESSOR RESOURCE AND EXECUTION PROTECTION METHODS AND APPARATUS - Embodiments include processing systems that determine, based on an instruction address range indicator stored in a first register, whether a next instruction fetch address corresponds to a location within a first memory region associated with a current privilege state or within a second memory region associated with a different privilege state. When the next instruction fetch address is not within the first memory region, the next instruction is allowed to be fetched only when a transition to the different privilege state is legal. In a further embodiment, when a data access address is generated for an instruction, a determination is made, based on a data address range indicator stored in a second register, whether access to a memory location corresponding to the data access address is allowed. The access is allowed when the current privilege state is a privilege state in which access to the memory location is allowed. | 12-05-2013 |
Lawrence Hausman, Selden, NY US
Patent application number | Description | Published |
---|---|---|
20090294523 | Method, System and Device for Identification from Multiple Data Inputs - A device, system and method including a mobile unit having a location sensor to detect location data of a unit; a biometric sensor to detect a biometric property of user of the unit; a display to prompt the user of the unit to input personalized data into for example an input interface; a memory to store identification data; a user input interface to receive identification data; a transmitter to wirelessly transmit location data, biometric data, personalized input and identification data; and a mobile power source to power the unit. | 12-03-2009 |
Marvin Hausman, Stevenson, WA US
Patent application number | Description | Published |
---|---|---|
20090286839 | PHYTONUTRIENT COMPOSITIONS FROM MUSHROOMS OR FILAMENTOUS FUNGI AND METHODS OF USE - This invention is directed to treating disease states or conditions associated with the treatment and prevention of neurodegeneration and neurodegenerative disease states, and treatment of radiation damage. The invention relates to novel phytonutrient compositions and compounds comprising L-ergothioneine and/or selenium. The invention also provides a method of administering these compositions and combinations to humans or animals in need thereof. | 11-19-2009 |
Marvin S. Hausman, Sherwood, OR US
Patent application number | Description | Published |
---|---|---|
20100076093 | USE OF ERGOTHIONEINE AS A PRESERVATIVE IN FOODS AND BEVERAGES - The invention relates to the novel use of ergothioneine and preferably, L ergothioneine, as a nutritional additive and preservative in foods, medicines, and/or beverages. According to the invention, the powerful antioxidant ergothioneine was found to be very stable over time in and to have no deleterious effects on taste or consistency of food and beverages even when stored, over a period of several years. In a preferred embodiment, ergothioneine may be used as a replacement for all or part of the antimicrobial/preservative sulfur dioxide or other sulfites traditionally used in the wine making process. | 03-25-2010 |
20110091579 | VITAMIN D2 ENRICHED MUSHROOMS AND FUNGI FOR TREATMENT OF OXIDATIVE STRESS, ALZHEIMER'S DISEASE AND ASSOCIATED DISEASE STATES - An filamentous fungi is disclosed with a naturally vitamin D enriched nutritional profile. These enriched mushrooms were shown to have a synergistic effect on longevity of subjects with both a normal and nutritionally deficient diets, improved tolerance to oxidative stress, and increased longevity in a Alzheimer's disease model. Surprisingly, vitamin D2 and D3 fed alone or in combination with nonenriched mushrooms did not produce similar effects. | 04-21-2011 |
20140121156 | NUTRITIONAL APPROACH TO THE CONTROL OF ANEMIA, DIABETES AND OTHER DISEASES OR CONDITIONS AND PREVENTION OF ASSOCIATED COMORBID STATES WITH THE USE OF ERGOTHIONEINE - Nutritional products, compositions, pharmaceutical preparations and methods of use are disclosed for the prevention, suppression and treatment of anemia and/or diabetes and its various associated comorbidities. Uses of Ergothioneine to neutralize free radicals and/or cytokines, reduce oxidative stress, prevent inflammation, stimulate red blood cell production with increased levels of hemoglobin, and/or stabilize iron in its normal 2 | 05-01-2014 |
20140363379 | NUTRITIONAL APPROACH TO THE USE OF ERGOTHIONEINE AND VITAMIN D2 FOR HAIR, NAIL AND SKIN GROWTH - Nutritional products, including food and/or beverage compositions, pharmaceutical and cosmetic preparations and methods of use are disclosed for the prevention, suppression and treatment of skin, hair, and nail conditions for the improvement of skin, hair and nail growth through the identification and/or use of stem cells, as well as maintenance of healthy tissues. Uses of Ergothioneine and/or Vitamin D to neutralize free radicals, and improve skin, hair and nail growth are disclosed. | 12-11-2014 |
Marvin S. Hausman, Stevenson, WA US
Patent application number | Description | Published |
---|---|---|
20100227307 | ERGOTHIONEINE AND/OR ITS DERIVATIVES AS A CELL PRESERVATIVE - The present invention relates to cell, tissue or derivatives thereof, preserving compositions for cells in culture, storage, or lyophilization. According to the invention ergothioneine is added as a supplement to such extender or preservative compositions. Sperm cells so treated showed increased motility when thawed compared to cells that were not treated with ergothioneine. | 09-09-2010 |
20120128711 | ANTI-INFLAMMATORY APPROACH TO PREVENTION AND SUPPRESSION OF POST-TRAUMATIC STRESS DISORDER, TRAUMATIC BRAIN INJURY, DEPRESSION AND ASSOCIATED DISEASE STATES - A composition and methods of use are disclosed for prevention and control of inflammation and oxidative stress and various associated medical conditions, including PTSD, chronic depression and traumatic brain injury. A composition providing a phytonutrient and enriched mushrooms having enhanced Vitamin D and ergothioneine are disclosed. The combined use of an enriched mushroom and phytonutrient provide a synergistic effect on cellular longevity and/or cellular rejuvenation of subjects with both a normal and nutritionally deficient diets, improved tolerance to oxidative and/or inflammatory stress, and increased cellular longevity and/or cellular rejuvenation as a result of the neutralization of free radicals and prevention of chronic inflammation. | 05-24-2012 |
20130035361 | USE OF ERGOTHIONEINE AS A PRESERVATIVE IN FOODS AND BEVERAGES - The invention relates to the novel use of ergothioneine and preferably, L ergothioneine, as a nutritional additive and preservative in foods, medicines, and/or beverages. According to the invention, the powerful antioxidant ergothioneine was found to be very stable over time in and to have no deleterious effects on taste or consistency of food and beverages even when stored, over a period of several years. In a preferred embodiment, ergothioneine may be used as a replacement for all or part of the antimicrobial/preservative sulfur dioxide or other sulfites traditionally used in the wine making process. | 02-07-2013 |
20150157648 | NUTRITIONAL APPROACH TO IMPROVING ATHLETIC PERFORMANCE AND REDUCING INJURY WITH L-ERGOTHIONEINE AND/OR VITAMIN D2 - Nutritional products, compositions, functional ingredients, medical foods, pharmaceutical preparations and methods of use are disclosed for support and improvement of athletic performance (strength, flexibility, endurance, balance, and conditioning), and prevention and repair of injuries, including improving or maintaining muscle mitochondrial health, stimulating muscle mitochondrial biogenesis as well as other indications as set forth herein. In addition, pharmaceutical, nutraceutical and nutritional medical food compositions that are useful in conditions, normal or abnormal, associated with mitochondrial dysfunction and altered biogenesis in organ systems consisting of skeletal muscle, smooth muscle and cardiac muscle are also disclosed. L-Ergothioneine (also referred to as Ergothioneine or ET), Vitamin D2 (Ergocalciferol) and/or other antioxidants are disclosed for use in pharmaceutical, nutraceutical and nutritional medical food compositions for uses to stimulate production of bioactive molecules, including but not limited to glutathione, alpha synuclein, and IL-6. | 06-11-2015 |
Michael R. Hausman, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110054346 | Systems and methods for Intra-operative semi-quantitative threshold neural response testing related applications - Systems and methods according to the present invention provide a means for determining, as an example, the health or location of nerves. A determination according to the present invention may include semi-quantitative threshold testing using intra-operative electrical stimulation to determine whether one or more nerves are functioning as expected. A determination according to the present invention may also be utilized to determine or predict the success of a surgical procedure that may affect the functioning of one or more nerves. Semi-quantitative analysis may be performed by comparing electrical stimulation intensity, or an approximation thereof, at which a threshold neural response is observed to an expected or previously applied electrical stimulation intensity, or an approximation thereof. | 03-03-2011 |
20110060238 | Systems and methods for intra-operative physiological functional stimulation - Improved assemblies, systems, and methods provide safeguarding against tissue injury during surgical procedures and/or identify nerve damage occurring prior to surgery and/or verify range of motion or attributes of muscle contraction during reconstructive surgery. Embodiments of methods according to the present invention provide the ability to intra-operatively simulate post-operative physiologic function of a body part. Such methods may be used during various surgical procedures, including tendon transfer procedures. Included are one or more steps of confirming paralysis or a weakened condition of a body part, confirming responsivity or operability of transfer tissue to supplement the functionality of the paralyzed or weakened part, and intra-operatively simulating post-operative functionality of the transfer tissue to enhance and/or predict the outcome of the surgical procedure. | 03-10-2011 |
20110060242 | Systems and methods for intra-operative stimulation within a surgical field - Improved assemblies, systems, and methods provide safeguarding against tissue injury during surgical procedures and/or identify nerve damage occurring prior to surgery and/or verify range of motion or attributes of muscle contraction during reconstructive surgery. Such improved assemblies may be utilized in embodiments of methods according to the present invention allowing, preferably by a single hand, manipulation, carrying, parameter adjustment and/or informational feedback generation from within a surgical field. Single-handed operation and easily identifiable feedback generation is desirable especially where focused attention is required, such as during surgery observed through a microscope. | 03-10-2011 |
20110060243 | Systems and methods for intra-operative regional neural stimulation - Systems and methods according to the present invention provide a means for determining, as an example, the health or location of nerves. Generally, embodiments according to the present invention may be used to verify the absence of nerve tissue along a prospective incision location to avoid damage caused by such incision. Alternatively or additionally, embodiments according to the present invention may be used to locate and/or hone in on a more precise location of one or more nerves. Electrical stimulation may be applied to tissue in an iterative fashion in one or more desired patterns and at one or more stimulation intensities to determine one or more regional neural responses and one or more focused neural responses. | 03-10-2011 |
20120296442 | SYSTEMS AND METHODS FOR INTRA-OPERATIVE PHYSIOLOGICAL FUNCTIONAL STIMULATION - Improved assemblies, systems, and methods provide safeguarding against tissue injury during surgical procedures and/or identify nerve damage occurring prior to surgery and/or verify range of motion or attributes of muscle contraction during reconstructive surgery. Embodiments of methods according to the present invention provide the ability to intra-operatively simulate post-operative physiologic function of a body part. Such methods may be used during various surgical procedures, including nerve transfer procedures. Included are one or more steps of confirming paralysis or a weakened condition of a body part, confirming responsivity or operability of transfer tissue to supplement the functionality of the paralyzed or weakened part, and intra-operatively simulating post-operative functionality of the transfer tissue to enhance and/or predict the outcome of the surgical procedure. | 11-22-2012 |
20140371622 | SYSTEMS AND METHODS FOR INTRA-OPERATIVE REGIONAL NEURAL STIMULATION - Systems and methods according to the present invention provide a means for determining, as an example, the health or location of nerves. Generally, embodiments according to the present invention may be used to verify the absence of nerve tissue along a prospective incision location to avoid damage caused by such incision. Alternatively or additionally, embodiments according to the present invention may be used to locate and/or hone in on a more precise location of one or more nerves. Electrical stimulation may be applied to tissue in an iterative fashion in one or more desired patterns and at one or more stimulation intensities to determine one or more regional neural responses and one or more focused neural responses. | 12-18-2014 |
20150313512 | PERCUTANEOUS STIMULATION DEVICE AND METHOD FOR DETECTING COMPARTMENT SYNDROME - A diagnosis device, and more particularly, a compartment syndrome diagnostic device is described herein. The diagnostic device may include a display that renders information associated with stimulation of a motor unit suspected of suffering from compartment syndrome. The diagnostic device may generate a stimulation signal for stimulating the motor unit through an electrode. The device may determine whether the motor unit is at risk for compartment syndrome based on the response of the motor unit to the stimulation. The diagnostic device may also measure pressure of a compartment. The device may determine whether the motor unit is at risk for compartment syndrome based on the measured pressure and the response of the motor unit to the stimulation. | 11-05-2015 |
Nicholas Hausman, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100239112 | TOOL FOR INSERTION AND REMOVAL OF IN-CANAL HEARING DEVICES - Methods, tools, and methods of manufacturing said tools are provided for inserting a hearing device deeply into the ear canal of a user and adjusting its medial-lateral position therein. The provided tools comprise a shaft. A distal end of the shaft can be coupled to the hearing device. The shaft is flexible to facilitate its insertion into the tortuous ear canal and minimize injurious contact with the ear canal. The length of the shaft can be adjusted to adjust the depth of insertion of the shaft into the ear canal, customizing the tool for an individual user. Medial advancement of the shaft into the ear canal is limited by a base, side extension, or mold coupled to a proximal portion of the shaft or other proximal part of the tool. | 09-23-2010 |
20120294467 | Tool For Insertion and Removal of In-Canal Hearing Devices - Methods, tools, and methods of manufacturing said tools are provided for inserting a hearing device deeply into the ear canal of a user and adjusting its medial-lateral position therein. The provided tools comprise a shaft. A distal end of the shaft can be coupled to the hearing device. The shaft is flexible to facilitate its insertion into the tortuous ear canal and minimize injurious contact with the ear canal. The length of the shaft can be adjusted to adjust the depth of insertion of the shaft into the ear canal, customizing the tool for an individual user. Medial advancement of the shaft into the ear canal is limited by a base, side extension, or mold coupled to a proximal portion of the shaft or other proximal part of the tool. | 11-22-2012 |
20140254847 | Tool For Insertion and Removal of In-Canal Hearing Devices - Methods, tools, and methods of manufacturing said tools are provided for inserting a hearing device deeply into the ear canal of a user and adjusting its medial-lateral position therein. The provided tools comprise a shaft. A distal end of the shaft can be coupled to the hearing device. The shaft is flexible to facilitate its insertion into the tortuous ear canal and minimize injurious contact with the ear canal. The length of the shaft can be adjusted to adjust the depth of insertion of the shaft into the ear canal, customizing the tool for an individual user. Medial advancement of the shaft into the ear canal is limited by a base, side extension, or mold coupled to a proximal portion of the shaft or other proximal part of the tool. | 09-11-2014 |
Nicholas H. Hausman, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20130309908 | CONSOLIDATED POWER TIPS - Consolidated power tips allow a power adaptor to be connected to disparately sized input ports of electronic devices. The consolidated power tips may be sized to balance insertion and pull-out forces for the disparately sized input ports. Deformable members may be added to the consolidated power tips for more desirable insertion and pull-out forces and improved electrical contact. For input ports with different electrical requirements, a mode selector may be added to the consolidated power tip to select between the electrical requirements of the different input ports. | 11-21-2013 |
Paul Hausman, San Ramon, CA US
Patent application number | Description | Published |
---|---|---|
20080214919 | SYSTEM AND METHOD FOR IMPLEMENTATION OF GLYCEMIC CONTROL PROTOCOLS - A system for implementing a wide-range of glycemic control protocols (e.g., Tight Glycemic Control protocols) in an automated, semi-closed or closed loop manner thereby eliminating common sources of system error is provided herein. More specifically, the system can include a blood glucose measuring device in communication with a wide-range of databases and/or interfaces thereby allowing for typically independent steps such as patient testing, result determination, protocol adjustment (suggestions as well as actual calculations of new dosages), meal information, scheduling of future testing in light of test results, and administration of medicine to be performed automatically in a semi-closed or closed loop manner. Furthermore, the system provides for ultimate flexibility by allowing a protocol administrator to continuously add, subtract, and/or modify various steps of the protocol while maintaining the integrity and safety of the system. Additionally, methods of implementing such glucose control protocols are also provided herein. | 09-04-2008 |
Phillip Hausman, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20090189759 | HYGIENE MONITORING SYSTEM - A method is provided for monitoring hygiene compliance. | 07-30-2009 |
Phillip J. Hausman, Cary, NC US
Patent application number | Description | Published |
---|---|---|
20110068930 | HYGIENE MONITORING SYSTEM - A method is provided for monitoring hygiene compliance. | 03-24-2011 |
20130120142 | HYGIENE COMPLIANCE REPORTING SYSTEM - A system and method is provided for monitoring hygiene compliance. | 05-16-2013 |
20140035744 | HYGIENE MONITORING SYSTEM - A system and method is provided for monitoring hygiene compliance. | 02-06-2014 |
20140292518 | HYGIENE MONITORING SYSTEM - A system and method is provided for monitoring hygiene compliance. | 10-02-2014 |
Richard Hausman, Waterville, OH US
Patent application number | Description | Published |
---|---|---|
20140134904 | ARTICLES INCLUDING FRIMS AND METHODS OF USING THEM - Certain embodiments described herein are directed to articles that provide less sag. In some examples, the articles can include a fiber reinforced thermoplastic polymer core layer comprising reinforcing fibers and a thermoplastic polymer, and a frim disposed on the fiber reinforced polymer core layer. In certain examples, the frim comprises a film coupled to a scrim comprising an effective basis weight to prevent substantial sag of the article, e.g., during a forming operation. | 05-15-2014 |
Richard Hausman, Gibsonburg, OH US
Patent application number | Description | Published |
---|---|---|
20110120936 | Anti-Biofouling Materials and Methods of Making Same - Anti-biofouling nanocomposite material at least partially loaded with copper or silver ions and methods for making same are disclosed. Metal affinity ligands are covalently bound to the polymers that are charged with the metal ions to allow for slow release of metals. | 05-26-2011 |
Richard Hausman, Soquel, CA US
Patent application number | Description | Published |
---|---|---|
20110047302 | PROGRAMMED I/O ETHERNET ADAPTER WITH EARLY INTERRUPTS FOR ACCELERATING DATA TRANSFER - In a Local Area Network (LAN) system, an Ethernet adapter exchanges data with a host through programmed I/O (PIO) and FIFO buffers. The receive PIO employs a DMA ring buffer backup so incoming packets can be copied directly into host memory when the PIO FIFO buffer is full. The adapter may be programmed to generate early receive interrupts when only a portion of a packet has been received from the network, so as to decrease latency. The adapter may also be programmed to generate a second early interrupt so that the copying of a large packet to the host may overlap reception of the packet end. The adapter to begin packet transmission before the packet is completely transferred from the host to the adapter, which further reduces latency. The minimal latency of the adapter allows it to employ receive and transmit FIFO buffers which are small enough to be contained within RAM internal to an Application Specific Integrated Circuit (ASIC) containing the transceiver, ethernet controller, FIFO control circuitry and the host interface as well. | 02-24-2011 |
Robert Hausman, Bridgewater, NJ US
Patent application number | Description | Published |
---|---|---|
20100246805 | CROSSTALK IDENTIFICATION FOR SPECTRUM MANAGEMENT IN BROADBAND TELECOMMUNICATIONS SYSTEMS - Crosstalk between subscriber loops used to transmit different broadband services through the same bundled telephone cable is a significant limitation to providing digital subscriber line services. A method for estimating the crosstalk, identifying the sources of the crosstalk and predicting additional sources of crosstalk are disclosed. The crosstalk sources are identified in the frequency domain by maximizing the correlation with a “basis set” of received crosstalk PSDs which consist of the cascade of a finite set of known transmit PSDs types times a representative set of crosstalk couplings. Multiple crosstalk types are identified with a technique of successive spectral subtraction. Once a type is identified the crosstalk disturber is compared against all other members of the complete set for that type. Additionally, Multiple Regression (MR) techniques and a Matching Pursuit (MP) algorithm are used to increase the ability of the system and method to identify various crosstalk disturbers. The identification of the crosstalk disturber is then used to perform crosstalk cancellation and spectrum management in a DSL system. | 09-30-2010 |
Robert F. Hausman, Cerrillos, NM US
Patent application number | Description | Published |
---|---|---|
20140180932 | PROCESS FOR DETERMINING REASONABLENESS OF VALUE CONCLUSION - Some embodiments of the invention include a method for determining the reasonableness of a valuation conclusion made for an object. In some embodiments, the method includes producing independent value estimates based on applying analytics to information within databases and producing additional independent value estimates derived from the applying the analytics to the information. The method includes comparing the additional information with the value conclusion. The method of some embodiments also includes generating a reasonableness report based on the comparisons. | 06-26-2014 |
Steven M. Hausman, Johnson City, TN US
Patent application number | Description | Published |
---|---|---|
20090083589 | Systems, devices, and/or methods for managing communications - Certain exemplary embodiments can provide a system, which can comprise a programmable logic controller (PLC). The system can comprise a serial communications port connected to the PLC. In certain exemplary embodiments, the system can comprise a controller adapted to enable a customer application program to access and control the serial communications port. | 03-26-2009 |